Search

everythinglearnresearchcommunity

for

Search:↓

Thyroid hormones help hair grow, reduce hair loss, and increase hair pigment.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Exercise and finasteride together improve ovary health in PCOS rats.

Excessive iodine from a cystic fibrosis supplement can cause hypothyroidism.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Young women with PCOS without additional risk factors may have normal heart function.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Serenoa repens may cause early puberty and should be used cautiously in children.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.